Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk ...

In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...

Interview insights explain how GLP-1R agonists access brain regions governing reward, motivation, and stress. Animal studies ...

Researchers found that individuals have distinct baseline levels of brain-derived proteins in cerebrospinal fluid, masking ...

Researchers found that cumulative exposure to disadvantaged neighborhoods predicted faster epigenetic aging across three ...

A large genetic analysis identified 66 high-confidence genes linked to anxiety disorders across major brain regions. Findings ...

Scientists identified the gene-expression profile of sleeping nociceptors, sensory neurons that drive spontaneous neuropathic ...

Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...

Researchers showed that teosinte gene fragments in modern corn suppress nitrifying and denitrifying soil bacteria, reducing ...

Researchers have developed a device that cuts protein sample consumption by as much as 97% while still producing high-quality ...

Analysis of US diet and health data shows adults consuming the most ultra-processed foods face a 47% higher risk of heart ...